OSE Immunotherapeutics SA (EPA:OSE)
3.290
+0.018 (0.55%)
Apr 2, 2026, 5:35 PM CET
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €73.76 million as of April 2, 2026. Its market cap has decreased by -44.72% in one year.
Market Cap
73.76M
Enterprise Value
81.62M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.29
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has decreased from 104.30M to 73.76M, a decrease of -29.28%. That is a compound annual growth rate of -3.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 73.76M | -36.12% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensorion | 218.76M |
| Cellectis | 218.50M |
| Transgene | 209.75M |
| ABIONYX Pharma | 129.82M |
| MaaT Pharma | 108.76M |
| Innate Pharma | 105.35M |
| Adocia | 95.32M |
| Valerio Therapeutics Société anonyme | 59.15M |